Cargando…

Early mRNA Expression of Neuroendocrine Differentiation Signals Predicts Recurrence After Radical Prostatectomy: A Transcriptomic Analysis

BACKGROUND: Neuroendocrine differentiation (NED) of prostate cancer (PC) is a process that often occurs under evolutionary pressure from pharmacologic blockade of androgen receptor signaling at advanced stages of the disease. Identifying a subset of early PC that has a higher likelihood to evolve in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlachostergios, Panagiotis J., Karathanasis, Athanasios, Papandreou, Christos N., Tzortzis, Vassilios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734499/ https://www.ncbi.nlm.nih.gov/pubmed/35059083 http://dx.doi.org/10.14740/wjon1423

Ejemplares similares

Expression of Fibroblast Activation Protein Is Enriched in Neuroendocrine Prostate Cancer and Predicts Worse Survival
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2022)

Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2015)

Upper Tract Urothelial Carcinoma: A Rare Malignancy with Distinct Immuno-Genomic Features in the Era of Precision-Based Therapies
por: Evmorfopoulos, Konstantinos, et al.
Publicado: (2023)

Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2012)

Expression of Neutral Endopeptidase, Endothelin-1, and Nuclear Factor Kappa B in Prostate Cancer: Interrelations and Associations with Prostate-Specific Antigen Recurrence after Radical Prostatectomy
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Biomarkers in Prostate-Specific Membrane Antigen Theranostics
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2021)

Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
por: Ando, Takashi, et al.
Publicado: (2020)

The Role of the Small Ubiquitin-Related Modifier (SUMO) Pathway in Prostate Cancer
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2013)

DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population
por: Samara, Maria, et al.
Publicado: (2021)

Selecting for predisposition to cancer cachexia
por: Gioulbasanis, Ioannis, et al.
Publicado: (2012)

Prostate Specific Membrane Antigen mRNA in Blood as a Potential Predictor of Biochemical Recurrence after Radical Prostatectomy
por: Joung, Jae Young, et al.
Publicado: (2010)

Orbital Metastasis of Breast Carcinoma
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2009)

The ubiquitin-proteasome system in glioma cell cycle control
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2012)

Basic Concepts in Metastatic Cardiac Disease
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2012)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

Primitive neuroectodermal tumor transformation of testicular teratoma
por: Karatzas, Anastasios, et al.
Publicado: (2018)

Health-Related Quality of Life Assessment in Daily Urologic Practice: A Survey of Greek Urologists
por: Mitsogiannis, Iraklis C, et al.
Publicado: (2022)

Radiofrequency-assisted, laparoscopic, clampless partial nephrectomy in patients with low-complexity small renal tumors: A retrospective cohort study
por: Zachos, Ioannis, et al.
Publicado: (2023)

The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 1: post-translational regulation
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2009)

The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 2: transcriptional regulation
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2009)

The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy
por: Post, Jennifer M., et al.
Publicado: (2011)

Predictive factors for biochemical recurrence in radical prostatectomy patients
por: Turk, Hakan, et al.
Publicado: (2015)

Chromatin changes predict recurrence after radical prostatectomy
por: Hveem, Tarjei S, et al.
Publicado: (2016)

Prediction of biochemical recurrence after laparoscopic radical prostatectomy
por: Bejrananda, Tanan, et al.
Publicado: (2023)

Characterization of a miRNA Signature with Enhanced Diagnostic and Prognostic Power for Patients with Bladder Carcinoma
por: Samara, Maria, et al.
Publicado: (2023)

Robot-assisted radical prostatectomy has lower biochemical recurrence than laparoscopic radical prostatectomy: Systematic review and meta-analysis
por: Lee, Seon Heui, et al.
Publicado: (2017)

Prognostic Factors for the Development of Biochemical Recurrence after Radical Prostatectomy
por: Kotb, Ahmed F., et al.
Publicado: (2011)

Recurrence of Prostate Cancer with Cutaneous Metastasis after Radical Prostatectomy
por: Patel, Parth, et al.
Publicado: (2015)

Biochemical recurrence after radical prostatectomy: what does it mean?
por: Tourinho-Barbosa, Rafael, et al.
Publicado: (2018)

Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Zaine, Hind, et al.
Publicado: (2021)

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2023)

AFP-producing hepatoid adenocarcinoma of the stomach: a case report
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2009)

Advanced Imaging for the Early Diagnosis of Local Recurrence Prostate Cancer after Radical Prostatectomy
por: Panebianco, Valeria, et al.
Publicado: (2014)

Contemporary Radical Prostatectomy
por: Fu, Qiang, et al.
Publicado: (2011)

Laparoscopic radical prostatectomy
por: Lipke, Michael, et al.
Publicado: (2005)

Current Options for Second-Line Systemic Therapy in Metastatic Renal Cell Carcinoma
por: Mitsogiannis, Iraklis C., et al.
Publicado: (2022)

Hypoxia-Inducible Factor-2-Altered Urothelial Carcinoma: Clinical and Genomic Features
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2022)

Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy
por: Kim, Minsu, et al.
Publicado: (2022)

Impact of capsular incision on biochemical recurrence after radical perineal prostatectomy
por: Kwak, K W, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_o0ku3mm9243ncrfin9ami2vh96